Dehydroepiandrosterone: A panacea for the ageing ovary?
Considerable improvements and advancements have been made in the treatment of infertility but poor ovarian reserve whether due to prematurely or a physiologically ageing ovary, continues to be one of the few unresolved problems of modern infertility care. Fertility researchers had been active for quite some time to find a way to help reverse the effects of ageing on the ovaries but none made an impact till the introduction of Dehydroepiandrosterone [DHEA]. DHEA a mild, and therapeutically well tolerated, male hormone has emerged as a real potential candidate to reverse the effects of ageing on ovaries. Apart from this, DHEA has also been postulated to improve egg and embryo quality, pregnancy rates and time to conception and reduces miscarriage rates. This review attempts to highlight the mechanism of action of this drug, its indications and its current status for treating women with decreased ovarian reserve.
IVF Specialist, Assisted Reproductive Technology Centre, Army Hospital (R&R), New Delhi 110 010, India.
Nikita
N
Naredi
IVF Specialist, Assisted Reproductive Technology Centre, INHS Asvini, Mumbai, India.
K
K
Sandeep
Graded Specialist (Anatomy), Military Hospital Ahmedabad, Gujarat, India.
V D S
VD
Jamwal
Senior Resident, Assisted Reproductive Technology Centre, Army Hospital (R&R), New Delhi 110 010, India.
N
N
Nagraj
Senior Resident, Assisted Reproductive Technology Centre, Army Hospital (R&R), New Delhi 110 010, India.
Seema
S
Rai
DHEA; Dehydroepiandrosterone; Premature ovarian ageing